XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net loss $ (6,071,053) $ (768,955)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of derivative liability 1,021,007 (2,407,089)
Stock-based compensation expense 924,291 250,415
Unrealized foreign exchange loss 0 (429,494)
Changes in operating assets and liabilities:    
Receivables 229,011 (110,329)
Prepaid expenses and other current assets 42,934 119,112
Accounts payable and accrued liabilities (239,324) (47,405)
Net cash used in operating activities (4,093,134) (3,393,745)
Cash flows from investing activities:    
Proceeds from the sale of short term investment 0 378,000
Net cash provided by investing activities 0 378,000
Cash flows from financing activities:    
Proceeds from the issuance of common stock and warrants 7,902,912 2,832,436
Share issuance costs (1,508,919) (141,100)
Proceeds from issuance of promissory note 0 200,000
Proceeds from exercise of stock options and warrants 1,493,946 0
Net cash provided by financing activities 7,887,939 2,891,336
Effect of foreign exchange rate changes on cash (266,178) (102,228)
Net increase (decrease) in cash and cash equivalents 3,528,627 (226,637)
Cash and cash equivalents at beginning of period 2,643,937 418,893
Cash and cash equivalents at end of period 6,172,564 192,256
Supplemental disclosure of non-cash activity:    
Fair value of warrants issued to agent for services in conjunction with the Offering 366,271 0
Fair value of liability classified warrants issued in conjunction with Private Placement $ 0 $ 532,523